232 related articles for article (PubMed ID: 31290353)
1. Clinical Features and Surgical Outcomes of Patients With Moyamoya Disease and the Homozygous RNF213 p.R4810K Variant.
Zhang Q; Ge P; Ma Y; Zhang D; Wang R; Zhang Y; Wang S; Cao Y; Zhao M; Zhao J
J Child Neurol; 2019 Nov; 34(13):793-800. PubMed ID: 31290353
[TBL] [Abstract][Full Text] [Related]
2. Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease.
Kim EH; Yum MS; Ra YS; Park JB; Ahn JS; Kim GH; Goo HW; Ko TS; Yoo HW
J Neurosurg; 2016 May; 124(5):1221-7. PubMed ID: 26430847
[TBL] [Abstract][Full Text] [Related]
3. Absence of the RNF213 p.R4810K variant may indicate a severe form of pediatric moyamoya disease in Japanese patients.
Hara S; Mukawa M; Akagawa H; Thamamongood T; Inaji M; Tanaka Y; Maehara T; Kasuya H; Nariai T
J Neurosurg Pediatr; 2022 Jan; 29(1):48-56. PubMed ID: 34624841
[TBL] [Abstract][Full Text] [Related]
4. RNF213 p.R4810K Variant and Intracranial Arterial Stenosis or Occlusion in Relatives of Patients with Moyamoya Disease.
Matsuda Y; Mineharu Y; Kimura M; Takagi Y; Kobayashi H; Hitomi T; Harada KH; Uchihashi Y; Funaki T; Miyamoto S; Koizumi A
J Stroke Cerebrovasc Dis; 2017 Aug; 26(8):1841-1847. PubMed ID: 28506590
[TBL] [Abstract][Full Text] [Related]
5. Association between p.R4810K Variant and Postoperative Collateral Formation in Patients with Moyamoya Disease.
Ge P; Ye X; Liu X; Deng X; Wang J; Wang R; Zhang Y; Zhang D; Zhang Q; Zhao J
Cerebrovasc Dis; 2019; 48(1-2):77-84. PubMed ID: 31578010
[TBL] [Abstract][Full Text] [Related]
6. Significant Association of the RNF213 p.R4810K Polymorphism with Quasi-Moyamoya Disease.
Morimoto T; Mineharu Y; Kobayashi H; Harada KH; Funaki T; Takagi Y; Sakai N; Miyamoto S; Koizumi A
J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2632-2636. PubMed ID: 27476341
[TBL] [Abstract][Full Text] [Related]
7. Genotype-Phenotype Correlation in Long-Term Cohort of Japanese Patients with Moyamoya Disease.
Nomura S; Yamaguchi K; Akagawa H; Kawashima A; Moteki Y; Ishikawa T; Aihara Y; Saito T; Okada Y; Kawamata T
Cerebrovasc Dis; 2019; 47(3-4):105-111. PubMed ID: 30947170
[TBL] [Abstract][Full Text] [Related]
8. Development of atherosclerotic-moyamoya syndrome with genetic variant of RNF213 p.R4810K and p.T1727M: A case report.
Liu Y; Wu X; Fan Z; Cheng J; Zhong L; Lin Y; Qu X
Clin Neurol Neurosurg; 2018 May; 168():163-166. PubMed ID: 29567577
[TBL] [Abstract][Full Text] [Related]
9. Impact of RNF213 founder polymorphism (p.R4810K) on the postoperative development of indirect pial synangiosis after direct/indirect combined revascularization surgery for adult Moyamoya disease.
Ito M; Kawabori M; Sugiyama T; Tokairin K; Tatezawa R; Uchino H; Kazumata K; Houkin K; Fujimura M
Neurosurg Rev; 2022 Jun; 45(3):2305-2313. PubMed ID: 35128622
[TBL] [Abstract][Full Text] [Related]
10. Can Moyamoya Disease Susceptibility Gene Affect Extracranial Systemic Artery Stenosis?
Nomura S; Aihara Y; Akagawa H; Chiba K; Yamaguchi K; Kawashima A; Okada Y; Kawamata T
J Stroke Cerebrovasc Dis; 2020 Feb; 29(2):104532. PubMed ID: 31806452
[TBL] [Abstract][Full Text] [Related]
11. Association of
Xue Y; Zeng C; Ge P; Liu C; Li J; Zhang Y; Zhang D; Zhang Q; Zhao J
Stroke; 2022 Sep; 53(9):2906-2916. PubMed ID: 35543128
[TBL] [Abstract][Full Text] [Related]
12. Renovascular hypertension and
Kim JY; Cho H
Clin Nephrol; 2021 Aug; 96(2):105-111. PubMed ID: 33769276
[TBL] [Abstract][Full Text] [Related]
13. Frequency of RNF213 p.R4810K, a susceptibility variant for moyamoya disease, and health characteristics of carriers in the Japanese population.
Cao Y; Kobayashi H; Morimoto T; Kabata R; Harada KH; Koizumi A
Environ Health Prev Med; 2016 Sep; 21(5):387-390. PubMed ID: 27365075
[TBL] [Abstract][Full Text] [Related]
14.
Ok T; Jung YH; Kim J; Park SK; Park G; Lee S; Lee KY
J Am Heart Assoc; 2022 Aug; 11(15):e025676. PubMed ID: 35876407
[TBL] [Abstract][Full Text] [Related]
15. RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance.
Zhang Q; Liu Y; Zhang D; Wang R; Zhang Y; Wang S; Yu L; Lu C; Liu F; Zhou J; Zhang X; Zhao J
J Neurosurg; 2017 Apr; 126(4):1106-1113. PubMed ID: 27128593
[TBL] [Abstract][Full Text] [Related]
16. RNF213 p.R4810K Polymorphism and the Risk of Moyamoya Disease, Intracranial Major Artery Stenosis/Occlusion, and Quasi-Moyamoya Disease: A Meta-Analysis.
Wang Y; Mambiya M; Li Q; Yang L; Jia H; Han Y; Liu W
J Stroke Cerebrovasc Dis; 2018 Aug; 27(8):2259-2270. PubMed ID: 29752070
[TBL] [Abstract][Full Text] [Related]
17. Association of RNF213 polymorphism and cortical hyperintensity sign on fluid-attenuated inversion recovery images after revascularization surgery for moyamoya disease: possible involvement of intrinsic vascular vulnerability.
Uchino H; Ito M; Tokairin K; Tatezawa R; Sugiyama T; Kazumata K; Fujimura M
Neurosurg Rev; 2023 May; 46(1):119. PubMed ID: 37166684
[TBL] [Abstract][Full Text] [Related]
18. Regression of periventricular anastomosis after indirect revascularization in pediatric patients with moyamoya disease.
Zheng EY; Hara S; Inaji M; Tanaka Y; Nariai T; Maehara T
J Neurosurg Pediatr; 2023 Dec; 32(6):719-728. PubMed ID: 37773770
[TBL] [Abstract][Full Text] [Related]
19. Clinical and Genetic Risk Factors of Long-Term Outcomes after Encephaloduroarteriosynangiosis in Moyamoya Disease in China.
Wang X; Zhang Z; Wang Y; Zou Z; Ta N; Hao F; Shang M; Li D; Zeng F; Han C; Nie F; Bao X; Yang Y; Wang H; Liang M; Yang R; Ou L; Wen L; Yang Z; Liu W; Duan L
J Stroke Cerebrovasc Dis; 2021 Jul; 30(7):105847. PubMed ID: 33992965
[TBL] [Abstract][Full Text] [Related]
20. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development.
Liu W; Morito D; Takashima S; Mineharu Y; Kobayashi H; Hitomi T; Hashikata H; Matsuura N; Yamazaki S; Toyoda A; Kikuta K; Takagi Y; Harada KH; Fujiyama A; Herzig R; Krischek B; Zou L; Kim JE; Kitakaze M; Miyamoto S; Nagata K; Hashimoto N; Koizumi A
PLoS One; 2011; 6(7):e22542. PubMed ID: 21799892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
